跳至主要内容
临床试验/NCT01361789
NCT01361789已完成4 期

COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined

Asker & Baerum Hospital1 个研究点 分布在 1 个国家目标入组 93 人开始时间: 2004年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
93
试验地点
1
主要终点
Postoperative VAS score at rest 24 hours after surgery

研究概览

简要总结

Recent studies on molar surgery have shown that a combination of a glucocorticoid and NSAID or COX-2 selective inhibitor gives better pain relief than either of the drugs used separately. The investigators group has also shown that adding dexamethasone on top of a regimen of paracetamol, NSAID and local anesthesia resulted in 45% painfree patients at rest after ambulatory breast cancer surgery.

The goal of this study is to test the NSAID + glucocorticoid concept in ACl repair. The investigators want to evaluate whether a selective COX-2 selective inhibitor or a glucocorticoid or a combination of both drugs, as part of a multimodal analgesic regime, can provide improved pain relief and shorter hospital stay in patients undergoing outpatient ACL surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Arthroscopic reconstruction of the anterior crucial ligament (ACL)
  • At least 18 years old
  • ASA I + II

排除标准

  • Known renal impairment
  • Liver failure and/-or an asthmatic condition
  • Pregnancy
  • Breast feeding

研究组 & 干预措施

COXIB

Active Comparator

40 mg parecoxib (Dynastat, Pfizer®) one hour before surgery and 40 mg valdecoxib (prodrug of parecoxib, Bextra, Pfizer®)were given 8 hour after surgery.

After retraction of parecoxib from the market:

Etoricoxib (Arcoxia, MSD) 120 mg given one hour before surgery

干预措施: parecoxib, valdecoxib, etoricoxib (Drug)

Dexamethasone

Active Comparator

dexamethasone 8 mg iv

干预措施: Dexamethasone (Drug)

COXIB and dexamethasone

Active Comparator

combination of coxib AND dexamethasone

干预措施: parecoxib, valdecoxib, parecoxib and dexamethasone (Drug)

结局指标

主要结局

Postoperative VAS score at rest 24 hours after surgery

时间窗: 24 hours

次要结局

  • Cumulated opioid consumption(24 hours)

研究者

发起方
Asker & Baerum Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验